Pages that link to "Q38472818"
Jump to navigation
Jump to search
The following pages link to Oncogene alterations in endometrial carcinoma (Q38472818):
Displaying 17 items.
- Identification of heregulin, a specific activator of p185erbB2 (Q24338146) (← links)
- SALL4 is a new target in endometrial cancer (Q28303958) (← links)
- Inferring pathway dysregulation in cancers from multiple types of omic data (Q30980125) (← links)
- Novel strategies for systemic treatment of endometrial cancer (Q34090973) (← links)
- Monoclonal antibody therapy (Q34236658) (← links)
- Correlation Between the Clinical Parameters and Tissue Phenotype in Patients Affected by Deep-Infiltrating Endometriosis (Q38892949) (← links)
- Oncogenes and onco-suppressor genes in female genital cancer. (Q41545163) (← links)
- Expression of c-ErbB2 in human neuroblastoma tissues, adrenal medulla adjacent to tumor, and developing mouse neural crest cells. (Q42040977) (← links)
- Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis (Q42621065) (← links)
- Ornithine decarboxylase as a therapeutic target for endometrial cancer (Q46636207) (← links)
- The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma. (Q47333181) (← links)
- Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium. (Q53275845) (← links)
- Virulence factors in endometrial cancer (Q70557980) (← links)
- Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies (Q72228246) (← links)
- Endometrial cancer (Q73291969) (← links)
- Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium (Q77441937) (← links)
- Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium (Q79384427) (← links)